Human Vaccines & Immunotherapeutics
Title Abbreviation
Hum Vaccin Immunother
Electronic ISSN
2164-554X
Readership
Biomedical Researchers, Clinical Pharmacologists, Epidemiologists, Immunologists, Pharmaco-Epidemiologists, Pharmacologists, Physicians, Public Health Professionals, Scientists
Scope
Human Vaccines & Immunotherapeutics publishes international research into vaccinology and immunotherapy, including novel and experimental vaccine exploration. Human Vaccines & Immunotherapeutics is sponsored by the International Society for Vaccines (ISV).
The aim of Human Vaccines & Immunotherapeutics is to provide a platform to present and discuss developments in vaccinology and immunotherapy. The journal covers the following topics: Research and development of novel vaccines and immunotherapeutics; Experimental vaccines and novel approaches in vaccination and immunotherapy; Vaccines and immunotherapeutics for treating non-infectious diseases, e.g., cancer; Preclinical studies and clinical trials; Licensed products and their use in the field; Impact of licensed vaccines and Immunotherapeutics on disease; Safety and perceptions of licensed vaccines; Prevention and treatment in the developing world; Epidemiology and pharmaco-economics.
The journal publishes original research articles, short reports, case reports, reviews and commentaries.
Sponsoring Association(s)
International Society for Vaccines (ISV)
Publisher Name
Taylor & Francis, Inc. - US
To see more details about Human Vaccines & Immunotherapeutics,
Subscribe Now!
Impact Factor
JCR Categories/Rank
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines